Bei Akademie registrieren
KMDA, IL0010941198

Kamada stock sets November 9 date for third-quarter results

Published on 11/05/2026 at 00:29 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Kamada stock is preparing its next quarterly update. Management will follow the release with a live investor call and discussion.

What Kamada investors should watch

  • Kamada will publish third-quarter and nine-month results before U.S. markets open.
  • Management will discuss the figures and answer questions during a live conference call.
  • The company is expanding its specialty plasma-derived and biosimilar portfolio.
KMDA, IL0010941198, Illustration mit AI erstellt.
KMDA, IL0010941198, Illustration mit AI erstellt.

Kamada Ltd. will publish its third-quarter and nine-month financial results before the U.S. market opens on Monday, November 9, 2026. The company announced the schedule on November 2 in a release carried by BioSpace.

Kamada's management will discuss the results during a conference call at 8:30 a.m. Eastern Time on November 9 and answer questions from investors. The call will also be webcast, giving investors a scheduled opportunity to assess the quarter and the company's outlook.

Portfolio expansion remains in focus

Kamada describes itself as a global biopharmaceutical company focused on marketed products for rare and serious conditions and specialty plasma-derived therapies. Its stated growth plan combines commercial expansion, third-party pharmaceutical distribution in Israel and the MENA region, plasma collection in the United States, and potential business development.

The company lists six FDA-approved specialty plasma-derived products, alongside KAMRAB and two equine-based anti-snake venom products. It also operates three FDA-approved plasma collection centers in Texas, according to the company's investor relations page.

Share price and next catalyst

Kamada stock traded at USD 7.42 on Lang & Schwarz at 4:00 p.m. ET on Wednesday, November 4, 2026. The November 9 results release is the next scheduled company event and will provide the next set of operating figures for investors.

Investors can follow the real-time quote of Kamada stock during the next trading session.

The Israeli market backdrop can be followed through current TA-35 market coverage.

Read more news and analyses on Kamada stock.

Kamada company facts

  • Company: Kamada Ltd.
  • ISIN: IL0010941198
  • Ticker: KMDA
  • Primary listing: Nasdaq Global Select
  • Share price: USD 7.42 at 4:00 p.m. ET on November 4, 2026
  • Business: Specialty plasma-derived therapies, marketed biopharmaceutical products and biosimilars
Disclaimer...
en | IL0010941198 | KMDA | boerse | 70460032 |